3-iodobenzylguanidine has been researched along with Bradykinesia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, SK; Chung, EJ; Kim, EG; Kim, MS; Kim, SJ; Oh, M; Oh, SJ; Seog, DH | 1 |
Chiaravalloti, A; Danieli, R; Di Biagio, D; Di Pietro, B; Olivola, E; Pierantozzi, M; Schillaci, O; Simonetti, G; Stampanoni, M; Stanzione, P; Stefani, A; Tavolozza, M | 1 |
Hashimoto, M; Oka, H; Suzuki, M; Taira, K; Urashima, M | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Bradykinesia
Article | Year |
---|---|
Differences in myocardial sympathetic degeneration and the clinical features of the subtypes of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Myocardium; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tremor | 2011 |
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG.
Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Female; Heart; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathectomy; Tremor | 2012 |
Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Hypokinesia; Male; Mediastinum; Middle Aged; Myocardium; Parkinson Disease; Phenotype; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis | 2007 |